Antibiotic Resistances

The overuse and misuse of antibiotics for decades increased evolutionary pressure on bacteria to acquire antibiotic resistance. Resistant bacteria have a global reach and infections claim at least 50,000 lives each year across Europe and the US.

The lack of detailed information on bacterial resistance profiles early in the patient management leads to the prescription of untargeted broad-spectrum antibiotics.

Our platform rapidly identifies the presence of key resistance markers such as methicilin, extended spectrum beta-lactamases and vancomycin, which will support clinicians to implement antibiotic stewardship programs.